Psychiatric comorbidities and prescribing tendencies of sleep medications and related medications in young people with insomnia: a United States commercial claims-based analysis.

ABSTRACT:

Study objectives

To characterize children and youth newly diagnosed with insomnia and to describe their use of sleep and other related prescription medications.

Methods

Within a commercial claims database (January 1, 2016-December 31, 2021), we identified children and youth (2-24 years) with a newly recorded insomnia diagnosis (G47.0x; F51.0x) and examined psychiatric diagnoses in the prior 6 months. We evaluated sleep and related prescription medications dispensed in the week after new insomnia diagnoses (i.e. trazodone, other antidepressants, hydroxyzine, alpha-agonists, benzodiazepines, non-benzodiazepine hypnotics "z-drugs," antipsychotics, and others). Analyses were stratified by age and psychiatric comorbidities.

Results

Among 68 698 children and 108 118 older y

SUBMITTER: Bushnell G 

PROVIDER: S-EPMC11082474 | biostudies-literature | 2024 May

REPOSITORIES: biostudies-literature